Case Report: Complete response after tislelizumab treatment in a hepatocellular carcinoma patient with abdominal lymph node metastasis

Case Report: Complete response after tislelizumab treatment in a hepatocellular carcinoma patient with abdominal lymph node metastasis

BackgroundAbdominal lymph node (ALN) metastasis is associated with a poor prognosis in patients with hepatocellular carcinoma (HCC) because of the limited number of effective therapeutic options available. Immunotherapy with immune checkpoint inhibitors, such as those targeting programmed death rece...

Full description

Bibliographic Details
Main Authors: Haihui Deng, Bin Chen, Deti Peng, Jian He, Weicheng Zhao, Tuantuan Chen, Zonggui Xie, Fuwen Pang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Immunology
Subjects:
hepatocellular carcinoma
immunotherapy
locoregional therapy
tislelizumab
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1163656/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1163656/full

Similar Items